2005, total pharmaceutical industry R & D investment accounted for the proportion of sales revenue on average only 1.02%, in addition to individual enterprises more than 5%, the majority of enterprises in a very low proportion of R & D investment. Meanwhile, the domestic venture capital market has not been established, the middle part of the technological innovation system a serious fracture.
Present, pharmaceutical research and development is still at the research institutes and universities, research institutions and medium-sized enterprise set up accounts for only 50%. Meanwhile, market-oriented pharmaceutical companies, researchers engaged in the technological transformation, due to talent evaluation and incentive mechanism is not perfect, driven by economic interests, there are still areas of scientific research personnel to operate the phenomenon of segregation, so that researchers carefully develop new drug development and not become the backbone of technological innovation.
Due to lack of professional and technical personnel and research matching conditions, most enterprises can not become the main pharmaceutical research and development, so some of the key industrial technology did not break the long-term, restricted to high-tech industries and high value-added downstream products in the field of deep processing extension; product replacement is slow, not been able to keep up and meet market demand. resulting pharmaceutical products in China in the international division of labor in a low area of medicine, the high end of the domestic market is also mainly imported or joint venture products occupy.
Medical insurance system, medical system and drug distribution system not yet formed a workable mechanism for the coordination and sustainable development, health care, hospital administration can not play a regulatory role, resulting in irrational drug use, disorderly market competition; the same time, in the present regardless of family medicine, prescription putting difficult circumstances, the hospital pharmacy drugs still account for the absolute monopoly of the consumer market.
The lack of international certification of products and international market experience
medicine is a special product, Governments in market access for such products have very stringent regulations and management, most of our products, chemical raw materials not obtained permits to enter the international market. in the pharmaceutical production process management and quality assurance system, the  and the international development there is still a certain gap between countries, through international certification of the manufacturers and products are few. domestic pharmaceutical enterprises generally lack experience in international drug market professionals and international capacity is weak.
Although  exports of chemical raw materials larger But the international market through the registration and certification of products is not more than the end of 2004 China achieved in Europe and the United States DMF COS certified products registered only 60 and 192, accounting for 3.6% of the global total and 4.3%, most of the products still the form of chemical products into the international market. If a large number of exports to India of penicillin industrial salt is the result of further processing in India only after the identity of the drugs into the U.S. and European markets.

Steady growth in sales in seven major pharmaceutical .2004 sales totaled 257.17 billion yuan. Among them, the pharmaceutical sales of 176.25 billion yuan, 74.69 billion yuan more than in 2000, the annual increase of 14.8%; sales of 68.15 billion yuan of herbal medicines and proprietary medicine , 2000 and 2004 increased by 14.3%; medical device category of commercial sales 4.26 billion yuan, representing a steady growth in 2000.
Regions and cross-industry mergers and acquisitions has accelerated the restructuring of large-scale circulation of medicine, intensive. chain , modern logistics and information technology, accelerate the restructuring of the field of medicine circulation and modern management methods. \200,000 (including the pharmaceutical chain enterprises included), which above county drug retailer 76,295, below the county drug retailer 94899 .2004 pharmaceutical chain enterprises increased to 1624, amounting to 63,000 stores and more than pharmaceutical retail market share accounts for about 60%, a major pharmaceutical retail market mode of operation. private enterprises in the field of medicine distribution sudden emergence as an important force in circulation. State-sponsored medical logistics, e-commerce project has completed and put into operation , a group of powerful enterprises in the modern pharmaceutical logistics and information technology to the fore. The emergence of pharmaceutical third party logistics for the industry and provide more choices. With opening up the field of pharmaceutical distribution services, foreign investment has begun to test of access to the circulation of medicine.
In the growing competition in the market, pharmaceutical retail market maintained a rapid development momentum, the annual growth rate of 15% or so. With the construction of the two networks and a new rural cooperative medical care system reform promote rural drug market has also been the development of the seven major categories .2004 pharmaceutical sales, rural sales of 24.5 billion, and has become a new growth point of the pharmaceutical market.
Corporate structure. While the full implementation of GMP and GSP certification, out of a number of backward enterprises, but many pharmaceutical companies, small, scattered, chaotic problem is not fundamentally resolved, internationally competitive the leading enterprises in the country still lacks .2004 pharmaceutical industry enterprises 4738, in which small enterprises account for 83.4%. from the per capita output measure, per capita output of large pharmaceutical companies is less than 30 million, far below the level of advanced countries. According to Medicine Business Association statistics,  pharmaceutical commercial enterprises in 3152, with annual sales of more than 50 million yuan and more than 500 key enterprises only, while the number of loss-making enterprises up to 1482. At present the leading pharmaceutical companies with annual sales in  remain at about tens of billions of with global pharmaceutical giant 400 to 500 billion dollars in performance compared to far cry.
Products, technology structure is irrational. domestic manufacturers still focus on producing some of the more mature and relatively low technical requirements for traditional generic drugs or medical devices products, with the varieties of the large number of production enterprises, excess capacity, duplication of production and a serious lack of variety of innovation and technological innovation, low degree of specialization, collaboration and poor, homogeneous market competition. to the highest anti-infective market sales, for example, up production of amoxicillin up to more than 300 companies, registered production ceftazidime, ceftriaxone, and other products over hundreds of companies. As of December 26, 2005, up to produce a class of drugs companies gatifloxacin reached 77. Vitamin C also appears the old products to expand the production scale of the problem of the blind, dropping lower and lower prices, even at the loss of the edge.

Coordinated regional economic development enterprise restructuring through various forms of joint, joint-stock transformation, accelerate organizational restructuring of the pharmaceutical industry, the growing scale enterprises. At present there are nearly 120 pharmaceutical companies in Shanghai, Shenzhen Stock Exchange, the Shenzhen SME Board and overseas listing , joint economic value proportion has grown from 35.6% in 2000 to 47.4% in 2005, the state-owned economy has increased from 29.0% down to 7.48%, three-owned economic sectors rose to 27.2% in 2004 when annual sales of more than 50 billion nationwide large pharmaceutical enterprise group has nine, more than 10 billion worth of major medical equipment manufacturers have two, and another three national pharmaceutical retail chain stores the number of over one thousand companies, 27 pharmaceutical retail chain stores number over a hundred.
Eastern coastal areas of the country's total economic scale medical 65.8%, of which the Yangtze River Delta region is the largest gathering of pharmaceutical industry zone, Jiangsu, Zhejiang and Shanghai provinces and the country's total output value of the pharmaceutical industry 27.3%, with 14 companies entered the national top 50 pharmaceutical companies strong sales, while sales of the top 20 global pharmaceutical companies already invested 15 factories in the region or the establishment of the headquarters. Jiangsu Province, gathered a group of multinational pharmaceutical Company production base in China; Zhejiang export base of chemical raw materials and intermediates begun to take shape; Shanghai has a strong R & D capability, the formation of the leading basic research, application development, clinical testing, production, distribution and sales of relatively complete industrial chain to the core area of Shanghai Pudong Zhangjiang biomedical industry base has been formed. Yangtze River Delta region has been gradually formed in the chain supporting industry clusters better.
Pearl River Delta market economy, private economy is developed in the chemical pharmaceutical preparations,  medicine, bio-pharmaceutical and medical equipment among the best in the country areas. Guangzhou has a strong industrial base and scale of the strength of  medicine,  medicine is better innovation resources; Shenzhen will have a better bio-pharmaceutical industry environment, gather a group of high-tech medical devices and biopharmaceutical enterprises.
Lu Beijing, Tianjin and the Bohai Rim Biotechnology Liao strong industrial base to a certain extent, municipalities in the pharmaceutical industry chain and value chain has strong complementarity, huge development potential. Beijing Medical research base and research and development ability, in biomedicine, medical equipment and other high-end value chain, has obvious strength; Hebei, Shandong, Liaoning, is an important pharmaceutical industrial base, characteristics in the chemical and pharmaceutical fields; Tianjin biotechnology R & D ability, high level of internationalization, in modern  medicine, bio-pharmaceuticals and other areas of the formation of certain advantages.

Of more than 400 biopharmaceutical companies, which have a production capacity of genetically engineered drugs are 114 enterprises , vaccine manufacturers 28 .2005 biopharmaceutical industry completed 35.37 billion yuan output value at current prices, from 2001 to 2005 increased 30.7%; product sales revenue in 2001 increased 31.2% in 2005, is the pharmaceutical industry one of the fastest growing areas ; from 2001 to 2005 net fixed assets of biological pharmaceutical industry reached 28.8% annual growth, is the focus of investment in the pharmaceutical cheap retro jordans sale industry. Interferon has been listed since 1989, has 27 kinds of biotech drugs to achieve a localization. domestically produced drugs continue to develop market, breaking the monopoly of imported products, the long-term situation of the domestic market, making tens of millions of patients benefited.
Vaccine products in  has become the world's largest producer, can produce 26 kinds of viruses to prevent the 41 types of vaccines annual production of over one billion doses of units, for the prevention of hepatitis B, polio, measles, whooping cough, diphtheria, tetanus and other common pediatric vaccine production capacity to 5 million people. domestically to meet domestic residents vaccines prevent disease, medical treatment at the same time, the World Health Organization has begun air jordan 11 space jams to provide vaccines for disease prevention in other countries.
in encouraging private and foreign economic cooperation and development process, the medical device industry has developed rapidly in 2005, achieved medical device industry output value of 35.25 billion yuan, from 2000 to 2005 increased 19.4%; to achieve sales revenue of 34.16 billion yuan, the annual increase of 20.9%. high-end medical equipment to speed up the localization process, the existing retro jordans 10 product replacement cycles, the overall industry and market supply capacity further improved. Whether the domestic market or exports, the share of modern medical equipment products have greater growth, especially in some medical imaging equipment for assembly in model into the development and production patterns, patient monitoring equipment must have occupied the domestic most of the market, B-mode ultrasound, linear accelerator, a number of clinical laboratory instruments and implantable biomaterial products have a place in the domestic market.

Quite right, it could have been left 2.60 = 2.50 +0.10, and the right of people feeling that it should be placed 2.40 2.50-0.10 bar, unfortunately it was 2.45, and only did 0.05, then we subconscious to the left side, 2.60 will be more to get started [as if according to our Player's psychology, customer wins we go to to 2.40 and now to 2.45 to 2.50 less than 0.05, in turn, to understand more than 2.50 is 2.45 -0.1 = 2.40 more than 0.05, will feel the dealer has not optimistic about the meaning of customer wins coupled with concerns about the draw 3.00 2.45 should have been comfortable than the psychological 2.40 is more reasonable or more than 0.05, while lowering draw from 3.2 to 3.0, while customer wins and a draw from the conduct of the instability of the visiting team suggests, in turn, saw that the main victory is 2.6 compared with meat or meet their own psychological disk], 2.45 less than the over 2.40 0.05 psychological discomfort, the results do, visiting the home team lore. This is a typical so-called experts Ladbrokes trick.
Look at one example, 1:1, Nagoya, Yokohama, Ladbrokes 2.50 3.20 2.40, or 2.50 X 2.50 this psychological inertia, so that you can see 2.50X2.40 is unbalanced psychological, if the 2.50 fixed, customer wins down from 2.50 0.10 to 2.40, this will bring out the 3.20 high, of course, the psychological 2.40 is that you'll worry about it will play out, and then 2.50, normal, no high or too low, so that 3.20 is a psychological barrier but the result? even a draw. [The teachers thought that this dish is to focus on the evolution of a draw, given to 2.40 Ladbrokes The customer wins meet the Player's psychological expectations disk, while a draw and that draw 3.2 a bit high, but the main victory of 2.50 is normal to see that its still out of the possible, but if given to a 2.6, you will feel Obviously the main difficulty winning shot, then saw this time a little higher compensation levels of 3.2, or customer wins should get started, results such as the teacher said, and 3.2 high to suppress a certain draw, and then to digest, if the draw to to 3.1, you will feel optimistic about 2.40 at the same time making the same on the draw are concerned, this will draw some of the Player's get started.
Well, this has involved a half to half the problem, such as Li Bo 2.37 induce you better than 2.4, although the meat of 0.03 or less true intentions of making that optimistic about the] fact, with 1.57 less than 0.02 to 1.55 more than the meat, but rather in terms of more value than 1.60 Buy By the same token, 2.63 0.03 than 2.6 more than the meat in fact, with 1.53 [0.03 than 1.50 more than the meat of] the same reason. but 2.37 is compared with the 2.40, with 1.57 to 1.60 almost the same satisfaction, but also does not produce Skip a scale, such as 2.37 is to 2.40, such as 1.57 is to 1.60, this will create a feeling of superiority arrived there to buy. And it is 2.63 and 2.60 contrast, if it is the sweetness of the fundamentals is the case, 2.63 will be very cost-effective, like 1.53, if the fundamentals are a bit excluded, then the 263 will scare people, like 153 that no meat, and not worth the investment So, this time, although the ratio of over 1.50 1.53 0.03 meat, but do not touch a bit Buy the feeling, because the Player of the fundamentals that at least 1.53, the meat did not give enough, if like a 1.55 or 1.57 .2.60, too, psychology is relative, in conjunction to analyze the fundamentals. [meaning all teachers understand you, my understanding is fundamental to the analysis based on their obtained a credit to buy or scare.